These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12527188)

  • 1. Influence of enteric citric acid on the release profile of 4-aminopyridine from HPMC matrix tablets.
    Martínez González I; Villafuerte Robles L
    Int J Pharm; 2003 Jan; 251(1-2):183-93. PubMed ID: 12527188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of enteric-coated lactose on the release profile of 4-aminopyridine from HPMC matrix tablets.
    Martínez-González I; Villafuerte-Robles L
    Pharm Dev Technol; 2004; 9(2):145-53. PubMed ID: 15202573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets.
    Espinoza R; Hong E; Villafuerte L
    Int J Pharm; 2000 May; 201(2):165-73. PubMed ID: 10878323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine.
    Nie S; Pan W; Li X; Wu X
    Drug Dev Ind Pharm; 2004 Jul; 30(6):627-35. PubMed ID: 15285336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process.
    Martínez-González I; Villafuerte-Robles L
    Int J Pharm; 2003 May; 257(1-2):253-64. PubMed ID: 12711180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets.
    Juárez H; Rico G; Villafuerte L
    Int J Pharm; 2001 Mar; 216(1-2):115-25. PubMed ID: 11274813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component.
    Kiortsis S; Kachrimanis K; Broussali T; Malamataris S
    Eur J Pharm Biopharm; 2005 Jan; 59(1):73-83. PubMed ID: 15567304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
    McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
    Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire core for sustained drug delivery.
    Mehuys E; Vervaet C; Remon JP
    J Control Release; 2004 Feb; 94(2-3):273-80. PubMed ID: 14744479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):316-22. PubMed ID: 9050799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets.
    Pose-Vilarnovo B; Rodríguez-Tenreiro C; Rosa dos Santos JF; Vázquez-Doval J; Concheiro A; Alvarez-Lorenzo C; Torres-Labandeira JJ
    J Control Release; 2004 Feb; 94(2-3):351-63. PubMed ID: 14744486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery.
    Turkoglu M; Ugurlu T
    Eur J Pharm Biopharm; 2002 Jan; 53(1):65-73. PubMed ID: 11777754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets.
    Xu G; Groves MJ
    J Pharm Pharmacol; 2001 Jan; 53(1):49-56. PubMed ID: 11206192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
    Siepmann J; Kranz H; Bodmeier R; Peppas NA
    Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.